Bank of New York Mellon Corp - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 49 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q2 2024$1,525,622
+45.1%
493,729
+21.1%
0.00%
Q1 2024$1,051,673
-7.9%
407,625
-10.8%
0.00%
Q4 2023$1,142,071
+24.6%
456,828
+1.2%
0.00%
Q3 2023$916,478
-11.6%
451,467
+0.2%
0.00%
Q2 2023$1,036,419
-19.1%
450,617
+6.6%
0.00%
Q1 2023$1,280,722
+31.3%
422,681
+1.0%
0.00%
Q4 2022$975,166
+32.5%
418,527
+8.6%
0.00%
Q3 2022$736,000
-23.5%
385,461
+8.6%
0.00%
Q2 2022$962,000
-12.1%
354,849
-3.4%
0.00%
Q1 2022$1,094,000
-20.3%
367,189
+4.0%
0.00%
Q4 2021$1,373,000
+24.6%
352,953
+37.4%
0.00%
Q3 2021$1,102,000
+51.6%
256,921
+7.1%
0.00%
Q2 2021$727,000
+325.1%
239,992
+366.8%
0.00%
Q1 2021$171,000
-14.5%
51,416
-8.7%
0.00%
Q4 2020$200,000
+257.1%
56,314
+217.5%
0.00%
Q3 2020$56,000
-92.1%
17,737
-93.1%
0.00%
Q4 2019$713,000
+82.4%
256,3270.0%0.00%
Q3 2019$391,000
+11.7%
256,327
+161.6%
0.00%
Q1 2019$350,000
-0.8%
97,968
+6.2%
0.00%
Q4 2018$353,000
-80.5%
92,282
-51.9%
0.00%
Q3 2018$1,813,000
+197.7%
191,857
+129.9%
0.00%
Q2 2018$609,00083,4590.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q1 2020
NameSharesValueWeighting ↓
QVT Financial LP 16,013,540$39,233,0001.19%
ARMISTICE CAPITAL, LLC 1,940,000$4,753,0001.12%
DAFNA Capital Management LLC 234,000$573,0000.50%
Alpha Wave Global, LP 1,655,162$4,055,0000.43%
Telemetry Investments, L.L.C. 150,000$368,0000.21%
LADENBURG THALMANN FINANCIAL SERVICES INC. 5,294,945$12,972,0000.18%
SABBY MANAGEMENT, LLC 792,617$1,942,0000.11%
K2 PRINCIPAL FUND, L.P. 443,887$1,088,0000.10%
Anson Funds Management LP 105,085$257,0000.08%
DIALECTIC CAPITAL MANAGEMENT, LP 25,000$61,0000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders